A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1531-1538

  Ogawa, Makoto ^a   Umehara, Kazunari ^a   Yu, Wen Gong ^a   Uekusa, Yasuhiro ^a   Nakajima, Chigusa ^a   Tsujimura, Takahiro ^b   Kubo, Takeshi ^a   Fujiwara, Hiromi ^a   Hamaoka, Toshiyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b SUMITOMO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER REGRESSION; CELL ADHESION; CONTROLLED STUDY; IMMUNOREGULATION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; CELL MOVEMENT; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-12; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033119468     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Trinchieri, G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood, 84: 4008-4027, 1994.
2. Brunda, M. J. Interleukin-12, J. Leukoc. Biol., 55: 280-288, 1994.
3. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cylokine with multiple biologic effects on human lymphocytes. J. Exp. Med., 170: 827-845, 1989.
4. Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospisil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C., and Trinchieri, G. Induction of interferon y production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med., 173: 869-879, 1991.
5. Brunda, M. J., Luistro, L., Warner, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med., 178: 1223-1230, 1993.
6. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., and Lotze, M. J. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol., 153: 1697-1706, 1994.
7. Zou, J. P., Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara, H., and Hamaoka, T. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-γ production by antitumor T cells. Int. Immunol., 7: 1135-1145, 1995.
8. Brunda, M. J., Luistro, L., Hendrzak, J. A., Fountoulakis, M., Garotta, G., and Gately, M. K. Role of interferon-γ in mediating the antitumor efficacy of interleukin-12. J. Immunother. Emphas. Tumor Immunol., 17: 71-77, 1995.
9. Yu, W.-G., Yamamoto, N., Takenaka, H., Mu, J., Tai, X.-G., Zou, J.-P., Ogawa, M., Tsutsui, T., Wijesuria, R., Yoshida, R., Herrrnann, S., Fujiwara, H., and Hamaoka, T. Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12. Int. Immunol., 8: 855-865, 1996.
10. Fujiwara, H., Zou, J. P., Herrmann, S., and Hamaoka, T. A sequence of cellular and molecular events involved in IL-12-induced tumor regression. Res. Immunol., 146: 638-644, 1995.
11. Ogawa, M., Tsutsui, T., Zou, J. P., Mu, J., Wijesuriya, R., Yu, W. G., Herrmann, S., Kubo, T., Fujiwara, H., and Hamaoka, T. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12. Cancer Res., 57: 2216-2222, 1997.
12. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
13. Yeo, T-K., and Dvorak, H. F. Tumor stroma. In: R. Colvin, A. Bhan, and R. McCluskey (eds.), Diagnostic Immunopathology, 2nd ed., pp. 685-697, New York: Raven Press, 1995.
14. Folkman, J., and Klagsburn, M. Angiogenic factors. Science (Washington DC), 235: 442-447, 1987.
15. Yoshida, T. O., Haraguchi, S., Miyamoto, H., and Matsuo, T. Recognition of RSV-induced tumor cells in syngeneic mice and semisyngeneic reciprocal hybrid mice. Gann Monogr. Cancer Res., 21: 201-212, 1979.
16. Hashimoto, M., Niwa, O., Nitta, Y., Takeichi, M., and Yokoro, K. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn. J. Cancer Res., 80: 459-463, 1989.
17. Ogata, M. Shimizu, J., Kosaka, H., Maekawa, R., Shimizu, K., Fujiwara, H., and Hamaoka, T. Expression of H-2 antigens and inducibility of antitumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcomas. Jpn. J. Cancer Res., 77: 1134-1141, 1986.
18. Mu, J., Zou, J. P., Yamamoto, N., Tsutsui, T., Tai, X. G., Kobayashi, M., Herrmann, S., Fujiwara, H., and Hamaoka, T. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res., 55: 4404-4408, 1995.
19. Tremblay, G. Stromal aspects of breast carcinoma. Exp. Mol. Pathol., 31: 248-260, 1979.
20. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
21. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
22. Mu, J., Abe, Y., Tsutsui, T., Yamamoto, N., Tai, X. G., Niwa, O., Tsujimura, T., Sato, B., Terano, H., Fujiwara, H., and Hamaoka, T. Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity. Jpn. J. Cancer Res., 87: 963-971, 1996.
23. Liotta, L. A., Rao, C. N., and Barsky, S. H. Tumor invasion and the extracellular matrix. Lab. Investig., 49: 636-649, 1983.
24. Nagy, J. A., Brown, L. F., Senger, D. R., Lank, N., Van-de-Water, L., Dvorak, A. M., and Dvorak, H. F. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim. Biophys. Acta, 948: 305-326, 1989.
25. Brown, L. F., Dubin, D., Lavigne, L., Logan, B., Dvorak, H. F., and Van-de-Water, L. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am. J. Pathol., 142: 793-801, 1993.
26. Grimwood, R. E., Ferns, C. F., Nielsen, L. D., Huff, J. C., and Clark, R. A. Basal cell carcinomas grown in nude mice produce and deposit fibronectin in the extracellular matrix. J. Investig. Dermatol., 87: 42-46, 1986.
27. Oyama, F., Hirohashi, S., Shimosato, Y., Titani, K., and Sekiguchi, K. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. Cancer Res., 51: 4876-4881, 1991.
28. Scarpa, S., Giuffrida, A., Palumbo, C., Vasaturo, F., Signorelli, P., Forni, G., Modesti, M., Ferrantini, M., Belardelli, F., Musiani, P., and Modesti, A. Extracellular matrix remodelling in a murine mammary adenocarcinoma transfected with the interferon-α 1 gene. J. Pathol., 181: 116-123, 1997.
29. Springer, T. A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol., 57: 827-872, 1995.
30. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76: 301-314, 1994.
31. Butcher, E. C., and Picker, L. J. Lymphocyte homing and homeostasis. Science (Washington DC), 272: 60-66, 1996.
32. Baggiolini, M., Dewald, B., and Moser, B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol., 55: 97-179, 1994.
33. Murphy, P. M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol., 12: 593-633, 1994.
34. Tanaka, Y., Adams, D. H., Hubscher, S., Hirano, H., Siebenlist, U., and Shaw, S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 β. Nature (Lond.), 361: 79-82, 1993.
35. + T cells in response to MIP-1 α and MIP-1 β. Science (Washington DC), 260: 355-358, 1993.
36. Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kelvin, D. J., and Oppenheim, J. J. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med., 177: 1809-1814, 1993.